2SPD-013 Economic impact of biosimilar infliximab use
Author(s) -
Carlos Iglesias Fernández,
S Ruiz-Fuentes,
S Belda-Rustarazo,
Celia Gómez-Peña,
R Morón-Romero,
P Gómez-Nieto
Publication year - 2018
Publication title -
pubmed central
Language(s) - English
Resource type - Conference proceedings
DOI - 10.1136/ejhpharm-2018-eahpconf.34
Subject(s) - biosimilar , infliximab , medicine , medical prescription , pharmacy , observational study , drug , intensive care medicine , pharmacology , family medicine , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom